Roger Sidhu - Sep 20, 2022 Form 4 Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Role: Chief Medical Officer
Signature: /s/ Roger Sidhu
Stock symbol: ERNA
Transactions as of: Sep 20, 2022
Transactions value $: $0
Form type: 4
Date filed: 9/21/2022, 07:00 PM
Previous filing: Mar 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ERNA	Common Stock	Options Exercise		+20.2K			20.2K	Sep 20, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ERNA	Restricted Stock Units	Options Exercise	$0	-20.2K	-25%	$0.00	60.5K	Sep 20, 2022	Common Stock	20.2K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit converts into one share of common stock.
F2	On September, 2021, the reporting person was granted 80,650 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date.